Triple

T9632001
Position Surface form Disambiguated ID Type / Status
Subject Katalin Karikó E232829 entity
Predicate employer P7 FINISHED
Object BioNTech E232831 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: BioNTech | Statement: [Katalin Karikó, employer, BioNTech]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: BioNTech
Context triple: [Katalin Karikó, employer, BioNTech]
  • A. BioNTech chosen
    BioNTech is a German biotechnology company best known for developing one of the first mRNA-based COVID-19 vaccines in partnership with Pfizer.
  • B. Pfizer–BioNTech
    Pfizer–BioNTech is a pharmaceutical partnership best known for developing one of the first widely authorized mRNA vaccines against COVID-19.
  • C. Regeneron Pharmaceuticals
    Regeneron Pharmaceuticals is a leading American biotechnology company known for developing innovative antibody-based therapies for serious diseases, including eye disorders, cancer, and inflammatory conditions.
  • D. Janssen Biotech
    Janssen Biotech is a biopharmaceutical company known for developing and manufacturing innovative biologic therapies, including the blockbuster monoclonal antibody Remicade.
  • E. Moderna
    Moderna is a biotechnology company best known for pioneering mRNA-based vaccines, including one of the first widely used COVID-19 vaccines.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69ca848940cc8190b97cec654cb3bb4a completed March 30, 2026, 2:11 p.m.
NER Named-entity recognition batch_69cd9b2783b48190a9929dc3e3cd2956 completed April 1, 2026, 10:24 p.m.
NED1 Entity disambiguation (via context triple) batch_69d18232e34c8190a19685ee9210e88b completed April 4, 2026, 9:27 p.m.
Created at: March 30, 2026, 8:11 p.m.